Clinical evaluation of dynamic arc conformal radiotherapy for paraaortic lymph node metastasis

Radiotherapy and Oncology

Volumn 67, Issue 1, 2003, Pages 113-118

  Aoki, Tetsuya ^a   Nagata, Yasushi ^a   Mizowaki, Takashi ^a   Kokubo, Masaki ^a   Negoro, Yoshiharu ^a   Takayama, Kenji ^a   Mitsumori, Michihide ^a   Sasai, Keisuke ^a   Hiraoka, Masahiro ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Complication; Dose volume histogram; Dynamic arc conformal radiotherapy; Intensity modulated radiation therapy; Multileaf collimator; Paraaortic lymph node metastasis

Indexed keywords

CISPLATIN; FLUOROURACIL;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYNAMIC ARC CONFORMAL RADIOTHERAPY; GASTROINTESTINAL DISEASE; HUMAN; KIDNEY DISEASE; LIVER DYSFUNCTION; LYMPH NODE METASTASIS; PARAAORTIC LYMPH NODE METASTASIS; PRIORITY JOURNAL; RADIATION DOSE; RECURRENT DISEASE; SPINAL CORD DISEASE; SURVIVAL RATE; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0038030027     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(02)00388-2     Document Type: Article

References (34)

1. Burman C., Kutcher G.J., Emami B., Goitein M. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys. 21:1991;123-135.
2. Chao K.S., Deasy J.O., Markman J., et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys. 49:2001;907-916.
3. Cox J.D., Stetz J., Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 31:1995;1341-1346.
4. Crawford J.S., Harisiadis L., McGowan L., Rogers C.C. Paraaortic lymph node irradiation in cervical carcinoma without prior lymphadenectomy. Radiology. 164:1987;255-257.
5. Cunningham M.J., Dunton C.J., Corn B., et al. Extended-field radiation therapy in early-stage cervical carcinoma: survival and complications. Gynecol Oncol. 43:1991;51-54.
6. Eisbruch A., Kim H.M., Terrell J.E., Marsh L.H., Dawson L.A., Ship J.A. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 50:2001;695-704.
7. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 21:1991;109-122.
8. Feuer G.A., Calanog A. Endometrial carcinoma: treatment of positive paraaortic nodes. Gynecol Oncol. 27:1987;104-109.
9. Grigsby P.W., Heydon K., Mutch D.G., Kim R.Y., Eifel P. Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys. 51:2001;982-987.
10. Grigsby P.W., Perez C.A., Chao K.S., Herzog T., Mutch D.G., Rader J. Radiation therapy for carcinoma of the cervix with biopsy-proven positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys. 49:2001;733-738.
11. Hicks M.L., Piver M.S., Puretz J.L., et al. Survival in patients with paraaortic lymph node metastases from endometrial adenocarcinoma clinically limited to the uterus. Int J Radiat Oncol Biol Phys. 26:1993;607-611.
12. Jolles C.J., Freedman R.S., Hamberger A.D., Horbelt D.V. Complications of extended-field therapy for cervical carcinoma without prior surgery. Int J Radiat Oncol Biol Phys. 12:1986;179-183.
13. Kiricuta I.C., Sauer J., Bohndorf W. Omission of the pelvic irradiation in stage I testicular seminoma: a study of postorchiectomy paraaortic radiotherapy. Int J Radiat Oncol Biol Phys. 35:1996;293-298.
14. Kodaira T., Karasawa K., Shimizu T., et al. Clinical efficacy of applying four-field portals to paraaortic irradiation in the treatment of cervical carcinoma. Radiat Oncol Invest. 7:1999;170-177.
15. Komaki R., Mattingly R.F., Hoffman R.G., Barber S.W., Satre R., Greenberg M. Irradiation of para-aortic lymph node metastases from carcinoma of the cervix or endometrium. Preliminary results. Radiology. 147:1983;245-248.
16. Malfetano J.H., Keys H. Aggressive multimodality treatment for cervical cancer with paraaortic lymph node metastases. Gynecol Oncol. 42:1991;44-47.
17. Morita K. Conformation radiotherapy and conformal radiotherapy. Soc Ther Radiol Oncol. 10:1995;281-291.
18. Munzenrider J.E., Doppke K.P., Brown A.P., et al. Three-dimensional treatment planning for para-aortic node irradiation in patients with cervical cancer. Int J Radiat Oncol Biol Phys. 21:1991;229-242.
19. Nagata Y., Okajima K., Murata R., et al. Development of an integrated radiotherapy network system. Int J Radiat Oncol Biol Phys. 34:1996;1105-1111.
20. Nagata Y., Okajima K., Murata R., et al. Development of the CT simulator and evaluation of its clinical efficacy. J Jpn Soc Ther Radiol Oncol. 7:1995;65-75.
21. Nori D., Valentine E., Hilaris B.S. The role of paraaortic node irradiation in the treatment of cancer of the cervix. Int J Radiat Oncol Biol Phys. 11:1985;1469-1473.
22. Nutting C.M., Convery D.J., Cosgrove V.P., et al. Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer. Int J Radiat Oncol Biol Phys. 48:2000;649-656.
23. Pilepich M.V., Krall J.M., Johnson R.J., et al. Extended field (periaortic) irradiation in carcinoma of the prostate - analysis of RTOG 75-06. Int J Radiat Oncol Biol Phys. 12:1986;345-351.
24. Pirzkall A., Carol M., Lohr F., Hoss A., Wannenmacher M., Debus J. Comparison of intensity-modulated radiotherapy with conventional conformal radiotherapy for complex-shaped tumors. Int J Radiat Oncol Biol Phys. 48:2000;1371-1380.
25. Piver M.S., Barlow J.J. High dose irradiation to biopsy confirmed aortic node metastases from carcinoma of the uterine cervix. Cancer. 39:1977;1243-1246.
26. Piver M.S., Vongtama V., Barlow J.J. Para-aortic lymph node irradiation for carcinoma of the uterine cervix using split course technique. Gynecol Oncol. 3:1975;168-175.
27. Portelance L., Chao K.S., Grigsby P.W., Bennet H., Low D. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys. 51:2001;261-266.
28. Rotman M., Pajak T.F., Choi K., et al. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20. J Am Med Assoc. 274:1995;387-393.
29. Takahashi S. Conformation radiotherapy. Rotation techniques as applied to radiography and radiotherapy of cancer. Acta Radiol Suppl. 242:1965;1-142.
30. Teh B.S., Mai W.Y., Uhl B.M., et al. Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose-volume analysis. Int J Radiat Oncol Biol Phys. 49:2001;705-712.
31. Therasse P., Arbuck S.G., Eisenhauer E.A., et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 92:2000;205-216.
32. Trotti A., Byhardt R., Stetz J., et al. Common toxicity criteria: version 2.0. An improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys. 47:2000;13-47.
33. Vigliotti A.P., Wen B.C., Hussey D.H., et al. Extended field irradiation for carcinoma of the uterine cervix with positive periaortic nodes. Int J Radiat Oncol Biol Phys. 23:1992;501-509.
34. Zelefsky M.J., Fuks Z., Happersett L., et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol. 55:2000;241-249.